Synaptogenix (NASDAQ:SNPX) Issues Quarterly Earnings Results

Synaptogenix (NASDAQ:SNPX) released its quarterly earnings data on Thursday. The company reported ($4.36) earnings per share for the quarter, Zacks reports.

Synaptogenix Stock Performance

NASDAQ:SNPX opened at $2.67 on Friday. Synaptogenix has a twelve month low of $2.15 and a twelve month high of $6.22. The firm’s fifty day simple moving average is $2.96 and its 200 day simple moving average is $3.02.

About Synaptogenix

Synaptogenix, Inc operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.